Aging & Drug Discovery

2018-05-23T05:34:29Z (GMT) by C. Gossens
In clinical research - and especially in neuroscience and elderly populations - objective, automated and high frequency measures of disease progression are hard to come by. Traditional physician-led tests are only done periodically, missing the fluctuations of disease activity that strongly affect patient's quality of life. They also lack the objectivity that is so important when developing medicines. By providing elderly patients with mobile sensors they carry day in and day out to conduct tests and capture the data, we are addressing this need.
We have established an end-to-end approach and technology platform with great potential. We have gained first uptake experiences with elderly patients and are developing the necessary data analysis techniques. Our experience will give other clinical studies the confidence that one can bring the required software and workflows to the clinic.




CC BY 4.0